Inoue H - Search Results

1

A tumor-suppressive role for trypsin in human cancer progression.

Yamashita K, Mimori K, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Among authors: inoue h. Cancer Res. 2003 Oct 15;63(20):6575-8. Cancer Res. 2003. PMID: 14583448

2

Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.

Yamashita K, Upadhay S, Mimori K, Inoue H, Mori M. Yamashita K, et al. Among authors: inoue h. Cancer. 2003 May 15;97(10):2412-9. doi: 10.1002/cncr.11368. Cancer. 2003. PMID: 12733139 Free article.

3

FHIT is up-regulated by inflammatory stimuli and inhibits prostaglandin E2-mediated cancer progression.

Mimori K, Ishii H, Nagahara H, Sudo T, Yamashita K, Inoue H, Barnard GF, Mori M. Mimori K, et al. Among authors: inoue h. Cancer Res. 2006 Mar 1;66(5):2683-90. doi: 10.1158/0008-5472.CAN-05-2509. Cancer Res. 2006. PMID: 16510588

4

PGP9.5 methylation in diffuse-type gastric cancer.

Yamashita K, Park HL, Kim MS, Osada M, Tokumaru Y, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Among authors: inoue h. Cancer Res. 2006 Apr 1;66(7):3921-7. doi: 10.1158/0008-5472.CAN-05-1511. Cancer Res. 2006. PMID: 16585221

5

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.

Yamashita K, Kim MS, Park HL, Tokumaru Y, Osada M, Inoue H, Mori M, Sidransky D. Yamashita K, et al. Among authors: inoue h. Mol Cancer Res. 2008 Jan;6(1):31-41. doi: 10.1158/1541-7786.MCR-07-0213. Mol Cancer Res. 2008. PMID: 18234960

6

Prognostic score of gastric cancer determined by cDNA microarray.

Inoue H, Matsuyama A, Mimori K, Ueo H, Mori M. Inoue H, et al. Clin Cancer Res. 2002 Nov;8(11):3475-9. Clin Cancer Res. 2002. PMID: 12429637

7

MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway.

Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, Yoshinaga K, Masuda T, Utsunomiya T, Alonso MA, Inoue H, Mori M. Mimori K, et al. Among authors: inoue h. Oncogene. 2003 May 29;22(22):3463-71. doi: 10.1038/sj.onc.1206378. Oncogene. 2003. PMID: 12776198

8

Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.

Yamashita K, Tanaka Y, Mimori K, Inoue H, Mori M. Yamashita K, et al. Among authors: inoue h. Int J Cancer. 2004 Jun 10;110(2):201-7. doi: 10.1002/ijc.20067. Int J Cancer. 2004. PMID: 15069682

9

N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.

Yoshinaga K, Inoue H, Utsunomiya T, Sonoda H, Masuda T, Mimori K, Tanaka Y, Mori M. Yoshinaga K, et al. Among authors: inoue h. Clin Cancer Res. 2004 Sep 1;10(17):5702-7. doi: 10.1158/1078-0432.CCR-03-0262. Clin Cancer Res. 2004. PMID: 15355896

10

Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.

Mimori K, Yamashita K, Ohta M, Yoshinaga K, Ishikawa K, Ishii H, Utsunomiya T, Barnard GF, Inoue H, Mori M. Mimori K, et al. Among authors: inoue h. Clin Cancer Res. 2004 Dec 15;10(24):8243-9. doi: 10.1158/1078-0432.CCR-04-0849. Clin Cancer Res. 2004. PMID: 15623600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,555 results

Search Page

Filters